Canaccord lowered the firm’s price target on UiPath (PATH) to $14 from $19 and keeps a Buy rating on the shares. The firm said UiPath delivered mixed Q4 results as it navigates near-term headwinds and makes progress on its strategic shift to agentic automation. Softer-than-expected FY26 guide coupled with a handful of pieces of cautious commentary on the earnings call are creating some weakness in shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- M&A News: UiPath (PATH) Supercharges AI Automation with Peak Acquisition
- UiPath’s Mixed Outlook: Hold Rating Amid Federal Segment Delays and Cloud Growth Potential
- UiPath downgraded to Underperform at BofA on weak outlook, few catalysts
- UiPath price target lowered to $11 from $13 at Wells Fargo
- UiPath’s Financial Outlook Impacted by Delayed Deals and Conservative Growth Forecast Amidst Economic Challenges